Statera Biopharmaincis A Clinical Stage Biopharmaceutical Company Based In Fort Collinscoloradofounded In 2003 As Cleveland Biolabsthe Company Rebranded In 2021 Following A Mergerstatera Focuses On Developing Next Generation Immunotherapies Aimed At Restoring Immune Health Through Immune Modulation And Homeostasis The Companyae S Pipeline Includes Therapies For Autoimmune And Inflammatory Diseasesoncologyand Infectious Diseasesstatera Utilizes Its Advanced Immunomodulating Multi Component Systemaimsplatform To Evaluate Complex Immune Responsesnotable Programs Include Entolimodwhich Was Developed For Acute Radiation Syndromestatera Collaborates With Research Institutions Such As The Cleveland Clinic And Roswell Park Comprehensive Cancer Centeras Well As The Armed Forces Radiobiology Research Instituteto Advance Its Therapeutic Developments
